return to profitability

nice to see CMP just stick its nose back into the black for FY07 as well as forecasting further growth for the year ahead.

also now have the sleep treatment device which will target 10x the sleep diagnostics market. one j/v partner has already signed up for the sleep treatment and more are expected. add to this the neuroscan and other branches of the business, revenues of $37 million, almost double the current market cap, and its quite plain to see that this is a legitimate biotech with a bright future ahead of itself. a logical takeover target for rmd at some point in the future imho...

also read about this market that they have their nose in. well worth holding at these prices i think...

Blood Flow Measurement Devices Market to Exceed $250 Million by 2010, According to New Report
Written by EditorsChoice
Wednesday, 01 August 2007

Global blood flow measurement devices market is projected to exceed US$250 million by 2010. The market is driven by growing proportion of elderly and obese population that contribute to significant rise in illnesses, thereby enhancing the volumes of procedures that require blood flow monitoring devices.

San Jose, California (PRWEB) July 16, 2007 -- Though blood flow measurement devices market (http://www.strategyr.com/MCP-3311.asp) is concentrated primarily in three areas of the world - United States, Europe and Japan, strong prospects emanate from Asia Pacific. Global Doppler blood flowmeter market (http://www.strategyr.com/MCP-3311.asp) is estimated at US$187 million for 2007.


The United States dominates the blood flow measurement devices market, accounting for more than 40% share in 2007. Electromagnetic flowmeters market (http://www.strategyr.com/MCP-3311.asp) in the region is projected to reach US$1.8 million by 2010. In Europe, the leading market, Germany is estimated at over US$17 million for 2007. By the year 2010, Laser Flowmeters market (http://www.strategyr.com/MCP-3311.asp) in the region is projected to reach US$2.2 million. Asia-Pacific (including Japan) represents the fastest growing market, with sales projected to exceed US$55 million by 2010.


Innovative approaches in product technologies have been the prime growth factor in driving the blood flow measurement industry. The risk of blood vessel narrowing increases with age with highest risk at over 60 years of age. As a result, new systems are developed for reliable and accurate continuous measurement of blood pressure, rate of fluid transfusion, blood volume analysis and cardiac blood flow. Improvement and advances in the field of cerebral blood flow measuring technology has drastically increased the clinical usage of this technology. Some of the major developments in the Ultrasonic blood-flow detectors and flowmeters devices highlighted in the study include the incorporation of digital memory and color-coded digital displays.


Players with dominant presence in the blood flow measurement devices market, profiled in the study comprise Atys Medical, Carolina Medical, Compumedics DWL, Huntleigh Diagnostics Ltd, Neoprobe Corporation, Cardiosonix, Ltd., Flowtronics, Inc., Transonic Systems, Inc., and VIASYS Healthcare.


The report titled "Blood Flow Measurement Devices: A Global Strategic Business Report" explores innovative approaches in product technologies that have been the prime growth factor in driving the industry. The report analyzes the market by three key technologies - Doppler Flowmeters, Laser Flowmeters, and Electromagnetic Flowmeters. The study offers an insight into the technological breakthroughs, product developments/introductions, and research and development activities of major global and regional market participants. Know more about technologies on the growth curve and technologies that have been relegated to a remote segment of the healthcare market through this study. A theoretical backdrop of blood flowmeters, review of non-invasive and invasive blood flow measurement techniques, relevant factors in blood flow measurement is provided to give a broader perspective.